Being told that you have lung cancer is one of the most frightening moments in a person’s life. Many patients want treatment ...

As discussed at a recent IVBM event, Robert Kratzke, MD, outlines essential biomarkers, NGS panel selection, and next steps ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...

The American Lung Association wants to increase uptake of screening and biomarker testing to improve lung cancer outcomes. (LunaKate/Getty Images) Guardant Health is joining in on the American Lung ...

Cizzle Bio, Inc., a Texas-based biotechnology company advancing biomarker blood tests for early detection of lung and gastric cancers, today announced the laboratory validation of its proprietary ...

“It's My Wish, We Need This Program”: Qualitative Reflections From People With High-Grade Brain Cancer Consenting to Postmortem Brain Donation Targeted therapy has transformed treatment of non–small ...

MET protein (also known as c-Met protein) overexpression (OE) is an emerging clinically relevant biomarker that is targetable with antibody-drug conjugates. c-Met protein’s prevalence varies, ...

Toward Sustainable Hematology/Oncology Fellowship Training Through Career-Aligned Specialization This retrospective study included patients with stage IIIB/IIIC/IV NSCLC treated within ONCare Alliance ...

Medical oncologist Dr. R. Julie Brahmer discusses biomarker testing and advanced treatment for lung cancer patients.

The discussion transitions to biomarker testing as an essential component of lung cancer diagnosis, with Dr. Florez emphasizing that diagnosis remains incomplete until molecular characterization is ...

The global PD-L1 Biomarker Testing Market is witnessing robust expansion as precision oncology, immunotherapy adoption, and ...

In 2022, Christy Scattarella felt like her brain was unraveling. The Portlander, then 63, kept misplacing items such as her ...